ALB and familial pancreatic carcinoma: Current guidelines routinely recommend neoadjuvant therapy for all patients with borderline resectable pancreatic cancer in well physical condition, including nanoparticle albumin-bound paclitaxel plus gemcitabine and Combined with sequential chemoradiotherapy or modified FOLFIRINOX solution (30, 40).